Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ISO Wants To Tinker With Quality Systems Standard 13485:2016. Let ISO Know What You Think By Nov. 9

Executive Summary

Device firms don't have to conform to the latest version of ISO 13485 until March 2019, yet the International Organization for Standardization (ISO) Technical Management Board is champing at the bit to open up the quality systems standard for a rewrite. In response, ISO Technical Committee 210 has developed a survey to determine how changing the standard will affect device-makers and other stakeholders. TC210 wants to "gather opinions from the users [of ISO 13485] to justify why no immediate revision is desired, especially in light of all the regulatory changes that are coming," TC210 delegate Kim Trautman says. The survey closes Nov. 9.

Despite the most recent version of ISO 13485 not even going into effect for another four months, the International Organization for Standardization (ISO) Technical Management Board is already looking to open up the standard for a rewrite.

The three-year transition period for ISO 13485:2016 ends on March 1, 2019. That's when firms that use the international quality systems standard (and are audited to it) must be certified to the new version.

ISO 13485:2016 is unusually structured for a newer ISO standard. When it was being developed, ISO Technical Committee 210, Working Group 1 – a subcommittee that oversees ISO 13485 revisions – received a waiver from the ISO technical board to not write the standard in a so-called "high-level" format.

Adopted by ISO in 2012, the format requires all published standards to be harmonized in construct, text, terms and definitions. But TC210/WG1 believed it would be troublesome to use that type of structure for a device-related standard. (Also see "It's A Green Light For ISO 13485: Revised Global Quality Systems Standard Finally Published" - Medtech Insight, 26 Feb, 2016.)

In the end, ISO 13485:2016 was based on the 2008 version of ISO 9001, which does not use the high-level approach. ISO 9001 is the general quality systems standard applicable to all industries and is the base standard of ISO 13485. (The most recent version of ISO 9001, published in 2015, uses the high-level approach, however.)

Now it seems the ISO Technical Management Board is rethinking its waiver and is pushing for ISO 13485 to be written in that high level.

"There has been pressure to have ISO 13485:2016 revised again and to start now the revisions process to issue a new standard in 2020 or 2021, when the three-year transition period for the 2016 version has not even concluded yet," Kim Trautman, a US delegate for ISO TC210, told Medtech Insight on Oct. 31.

In response, TC210 has developed an industry survey to determine how a rewrite of the standard will affect device-makers and other stakeholders. The survey, which closes on Nov. 9, can be found at surveymonkey.com/r/3T7Z2DF.

"The survey is trying to capture the voice of the standard user," ISO TC210 delegate Kim Trautman says.

Trautman, who also is executive VP of medical device international services for consulting firm NSF International, says TC210 wants to "gather opinions from the users [of ISO 13485] to justify why no immediate revision is desired, especially in light of all the regulatory changes that are coming."

She pointed to the impending implementation of the EU's Medical Device and IVD Regulations in 2020 and 2022, respectively, as two big reasons not to tinker with ISO 13485 right now. (Check out Medtech Insight's interactive timeline for worldwide regulatory deadlines here.)

Trautman also noted that changing the standard now could affect US FDA's efforts to harmonize its Quality System Regulation with ISO 13485, the first draft of which is expected to come in 2019.  (Also see "QSR Author Kim Trautman Predicts What A Mash-Up Of FDA's Quality System Regulation And ISO 13485 Might Look Like" - Medtech Insight, 15 Aug, 2018.)

Further, a rewrite of the standard would mean the International Medical Device Regulators Forum (IMDRF) would have to review and revise the Audit Model and Audit Model Companion Document for its Medical Device Single Audit Program, she said.

MDSAP – which maps to ISO 13485 – allows firms to undergo one audit by an accredited third party to satisfy quality regulations for five countries: the US, Canada, Brazil, Japan and Australia.  (Also see "Compliance Corner: 8 Handy Tips From An MDSAP Auditor To Help You Ace Your Next Audit" - Medtech Insight, 29 Oct, 2018.)

"The survey is trying to capture the voice of the standard user – it closes on Nov. 9 before the TC210 meetings in Seoul, Korea, the week of Nov. 12 so TC210 can make a formal reply to the ISO Technical Management Board," Trautman said.

From the editors of The Gray Sheet

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123522

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel